Outpace Bio

About:

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Website: https://www.outpacebio.com

Twitter/X: OutpaceBio

Top Investors: Lyell Immunopharma, Alexandria Venture Investments, RA Capital Management, Qiming Venture Partners, Abstract Ventures

Description:

Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.